Fischer Medical Ventures
NSE: FISCHER · ISIN INE771F01041 · Healthcare
₹25.09+0.22 (+0.88%)
Monday 9 November, 12:47 IST. Delayed. Source: Yahoo Finance.
Price chart
₹25.09 +0.22 (+0.88%) today
The day
- Previous close
- ₹24.87
- Open
- ₹25.00
- Day high
- ₹25.32
- Day low
- ₹24.50
Listed on NSE since 10 July 2025.
Key numbers
- Market value
- ₹1,737.63 Cr
- P/E (trailing)
- 10.63
- EPS (trailing)
- ₹2.34
- Price to book
- 4.18
- Dividend yield
- 0.21%
- Debt to equity
- 0.28
- Profit margin
- 8.2%
- Beta
- 0.26
- Volume today
- 1.41 L
- Average volume
- 11.67 L
Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.
Revenue and profit
| Year | Revenue | Net profit |
|---|---|---|
| FY23 | ₹17.95 L | ₹-3.65 L |
| FY24 | ₹20.98 Cr | ₹1.84 Cr |
| FY25 | ₹110.70 Cr | ₹1.48 Cr |
| FY26 | ₹308.58 Cr | ₹32.21 Cr |
Source: Yahoo Finance, from annual reports. Consolidated where reported. EPS before FY26 is not shown: the share count changed (a bonus, split or merger), so earlier figures would not compare.
Quarterly results
| Quarter | Revenue | Net profit | Profit vs year ago |
|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | ₹82 Cr | ₹4 Cr | −24.3% |
| Q4 FY26Jan–Mar 2026Audited | ₹98 Cr | ₹-7 Cr | – |
| Q3 FY26Oct–Dec 2025 | ₹101 Cr | ₹7.38 L | – |
| Q2 FY26Jul–Sep 2025 | ₹86 Cr | ₹-78,000 | – |
| Q1 FY26Apr–Jun 2025 | ₹23 Cr | ₹5 Cr | – |
Source: Fischer Medical Ventures’s results filed with NSE, consolidated (the whole group). Net profit is the share of Fischer Medical Ventures’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.
Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.
Balance sheet
| As on | March 2026 | September 2025 |
|---|---|---|
| Fixed assets | ₹15 Cr | ₹24 Cr |
| Investments | ₹118 Cr | ₹121 Cr |
| Inventories | ₹13 Cr | ₹5 Cr |
| Owed by customers | ₹289 Cr | ₹203 Cr |
| Cash and equivalents | ₹12 Cr | ₹12 Cr |
| Total assets | ₹671 Cr | ₹468 Cr |
| Borrowings | ₹72 Cr | ₹15 Cr |
| Total liabilities | ₹286 Cr | ₹107 Cr |
| Shareholders’ equity | ₹384 Cr | ₹360 Cr |
Source: Fischer Medical Ventures’s half-yearly statements of assets and liabilities filed with NSE, consolidated. Companies file these every September and March.
About Fischer Medical Ventures
Fischer Medical Ventures Limited engages in the manufacture, distribution, leasing, and maintenance of medical equipment in India and internationally. Its product portfolio includes magnetic resonance imaging (MRI) systems; preventive health kiosks; e-health access points; software solutions; cancer, TB screening, and handheld x-ray; spincare technology; nutraceuticals; mental health solutions; contactless screening solutions; and CT scan systems, as well as preventive diagnostic devices and ancillary medical instruments. The company was formerly known as Fischer Chemic Limited and changed its name to Fischer Medical Ventures Limited in March 2024. Fischer Medical Ventures Limited was incorporated in 1993 and is headquartered in Chennai, India.
- Industry
- Medical Devices
- Based in
- Chennai
- Employees
- 16
Company website · Profile: Yahoo Finance
In the news
All newsNo headlines name Fischer Medical Ventures in the last day or two.
Dividends and corporate actions
All companies- Dividend - Re 0.05 Per Share
Dividend · ex-date 22 September 2026
- Dividend - Rs 0.005 Per Share
Dividend · ex-date 22 September 2025
- Face Value Split (Sub-Division) - From Rs 10/- Per Share To Re 1/- Per Share
Split · ex-date 12 September 2025
Source: NSE. Latest first.
Information only, not investment advice. Prices are delayed.